Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Conditions: Influenza, Human; Flu, Human; Flu, Avian; Influenza; Influenza A Virus, H5N1 SubtypeInterventions: Biological: Novartis Investigational H5N1 vaccine; Biological: Novartis Investigational H5N1 vaccine; Biological: Novartis Seasonal Influenza Vaccine; Biological: Novartis Seasonal Influenza VaccineSponsors: Novartis; Novartis VaccinesRecruiting - verified April 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | H5N1 | Influenza | Influenza Vaccine | Research | Vaccines